ロード中...
Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target
BACKGROUND: Most cancer deaths result from tumor cells that have metastasized beyond their tissue of origin, or have developed drug resistance. Across many cancer types, patients with advanced stage disease would benefit from a novel therapy preventing or reversing these changes. To this end, we hav...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345230/ https://ncbi.nlm.nih.gov/pubmed/28283022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3169-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|